Workers' Comp
Webcast: Workers' Compensation Legislation Addressing Essential Workers Affected by COVID-19
April 27, 2020
MIN READ
More stories
Workers' Comp
Article
Ask The Pharmacist: Marijuana and Controlled Substance Classifications
Recently, the U.S. Department of Justice (DOJ) proposed rescheduling marijuana from a Schedule I to a Schedule III controlled substance. This change follows a review requested by President Biden in 2022 and supported by medical and legal evaluations from the Department of Health and Human Services (HHS) and the Justice Department’s Office of Legal Counsel (OLC). The rulemaking process will include public notice, comments and an administrative hearing before any final decision is made.
Workers' Comp
Article
The Intelligence Report
Enlyte has partnered with Snowflake to bring next generation data capabilities. A data platform built to store and centralize access to data quickly and easily is the key to developing advanced analytics.
Workers' Comp
Article
Navigating the Complex Landscape of Utilization Review in Workers' Compensation
Learn about the crucial role of Utilization Review (UR) in the workers' compensation system, the importance of regulatory compliance, and the impact of state-by-state jurisdictional nuances.
Workers' Comp
News Release
Enlyte’s Q2 Medical Price Index Shows Increases In Comp and Auto Injury Services
Medical costs nationally have risen 11% in workers’ comp and 5% in auto first-party over the past four years, despite a slowing of growth over the past two years, according to new data released by Enlyte today.
Workers' Comp
Podcast
Return-to-work strategies for LGBTQ+ Injured Employees
Celebrate Pride Month by reflecting on the progress of LGBTQ+ equality and addressing health care disparities. Join Genex case manager Chikita Mann, MSN, RN, CCM, as she explores this crucial topic.
Workers' Comp
Article
Looking Beyond the Numbers of Enlyte’s Medical Price Index
In this quarter’s Enlyte Executive Insight, Michele Hibbert, senior vice president of regulatory compliance management, discusses the latest results from Enlyte’s medical price index and how it impacts the industry.